Location History:
- Los Angeles, CA (US) (1994 - 2000)
- Chapel Hill, NC (US) (2016 - 2018)
Company Filing History:
4 out of 484 
4 out of 2,009 
7 out of 832,843 Years Active: 1994-2018
Title: **Edward D. Levin: Innovator in Neuropharmacology**
Introduction
Edward D. Levin is a distinguished inventor and researcher based in Chapel Hill, North Carolina. With a remarkable portfolio of four patents, he has made significant contributions to the fields of neuropharmacology and medicinal chemistry, particularly concerning the treatment of various neurological disorders.
Latest Patents
Levin's latest patents include innovative compounds that target nicotinic acetylcholine receptors, which are crucial for numerous neurological functions. The first patent, titled "2,5-disubstituted-pyridyl nicotinic ligands, and methods of use thereof," focuses on heterocyclic compounds that show potential for treating a range of conditions, including Alzheimer's disease, Parkinson's disease, anxiety disorders, and substance abuse issues. His second patent, "Phenyl-substituted nicotinic ligands, and methods of use thereof," similarly unveils compounds aimed at addressing disorders such as addiction, obesity, and various psychiatric conditions, showcasing his extensive research into therapeutics for complex ailments.
Career Highlights
Throughout his career, Edward D. Levin has held significant roles at prestigious institutions such as Duke University and Georgetown University. His work in these esteemed universities has facilitated groundbreaking research and development of pharmacological therapies that leverage the potential of nicotinic receptors in the brain.
Collaborations
Levin has collaborated with prominent researchers, including Yingxian Xiao and Kenneth J. Kellar, further amplifying the impact of his discoveries. These collaborations have enabled the sharing of expertise and resources, contributing to innovative solutions in the field of neuropharmacology.
Conclusion
In conclusion, Edward D. Levin stands out as a key figure in the innovation landscape, particularly in the realm of treatments for neurological disorders. His patents not only reflect his ingenuity but also contribute to addressing some of the most pressing health challenges faced by society today. As he continues to advance his research, the potential for new therapeutic approaches remains promising.